Recent Security Class Actions

Ventyx Biosciences Inc. Common Stock (NASDAQ: VTYX)

Company Name:Ventyx Biosciences Inc. Common Stock
Stock Symbol:NASDAQ: VTYX
Class Period Start:10/21/2021
Class Period End (inclusive):11/06/2023
Filing Deadline:04/30/2024

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that: (i) VTX958 was less effective in treating psoriasis than Defendants had led investors to believe; (ii) as a result, VTX958’s clinical and/or commercial prospects were overstated; (iii) accordingly, the Company had misrepresented its ability to develop and commercialize effective product candidates; (iv) Ventyx’s post-IPO business prospects were thus inflated; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.